Streamlining Medical Trials for Enhanced Affected person Care and Collaboration
Large Bio, a number one supplier of personalised oncology options, shall be collaborating within the prestigious American Society of Medical Oncology (ASCO) annual assembly from June 2nd to June sixth. The occasion serves as a platform for sharing groundbreaking developments in most cancers care, and Large Bio is happy to unveil its modern ChatGPT-powered chatbot platform that includes AskFiona AI and DrArturo AI.
The ChatGPT-powered chatbot platform developed by Large Bio goals to revolutionize how most cancers sufferers, referring physicians, and website principal investigators entry and work together with medical trial info. With AskFiona AI because the preliminary level of contact, sufferers can obtain complete insights into medical trials, understanding their goal and assessing eligibility. The platform seamlessly escalates sufferers to DrArturo AI, offering tailor-made details about particular medical trials, together with therapy particulars, schedules, nearest therapy amenities, and extra.
Large Bio’s presence at ASCO 2023 highlights their dedication to driving progress in most cancers therapy and enhancing affected person care. Don’t miss the chance to discover their groundbreaking improvements firsthand. You possibly can see extra particulars in quickly.